Meta-analysis of the risk of subsequent mood episodes in bipolar disorder

Psychotherapy and Psychosomatics

Volumn 86, Issue 2, 2017, Pages 90-98

  Radua, Joaquim ^a,d,e,f   Grunze, Heinz ^g   Amann, Benedikt L ^a,b,c,d  

^a FIDMAG GERMANES HOSPITALÀRIES RESEARCH FOUNDATION   (Spain)

^b HOSPITAL DEL MAR   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^d CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE SALUD MENTAL CIBERSAM   (Spain)

^e KAROLINSKA INSTITUTE   (Sweden)

^f KING'S COLLEGE LONDON   (United Kingdom)

^g PARACELSUS MEDICAL UNIVERSITY   (Austria)

Author keywords

Bipolar disorder; Meta analysis; Recurrence; Relapse

Indexed keywords

ARTICLE; BIPOLAR DISORDER; BIPOLAR I DISORDER; BIPOLAR II DISORDER; DEPRESSION; HUMAN; MANIA; META ANALYSIS; MIXED MANIA AND DEPRESSION; MOOD DISORDER; PRIORITY JOURNAL; RISK ASSESSMENT; SYSTEMATIC REVIEW; AFFECT; CLASSIFICATION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENT DISEASE; RISK FACTOR;

AFFECT; BIPOLAR DISORDER; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECURRENCE; RISK FACTORS;

EID: 85013102382     PISSN: 00333190     EISSN: 14230348     Source Type: Journal    
DOI: 10.1159/000449417     Document Type: Article

References (50)

1. Zimmerman M: Screening for bipolar disorder: confusion between case-finding and screening. Psychother Psychosom 2014; 83: 259-262
2. Goodwin FK, Jamison KR: Manic-Depressive Illness, ed 2. New York, Oxford University Press, 2007
3. Post RM, Altshuler LL, Frye MA, Suppes T, Keck PE Jr, McElroy SL, Leverich GS, Luckenbaugh DA, Rowe M, Pizzarello S, Kupka RW, Grunze H, Nolen WA: Complexity of pharmacologic treatment required for sustained improvement in outpatients with bipolar disorder. J Clin Psychiatry 2010; 71: 1176-1186
4. Judd LL, Schettler PJ, Akiskal HS, Coryell W, Leon AC, Maser JD, Solomon DA: Residual symptom recovery from major affective episodes in bipolar disorders and rapid episode relapse/recurrence. Arch Gen Psychiatry 2008; 65: 386-394
5. Perlis RH, Ostacher MJ, Patel JK, Marangell LB, Zhang H, Wisniewski SR, Ketter TA, Miklowitz DJ, Otto MW, Gyulai L, Reilly-Harrington NA, Nierenberg AA, Sachs GS, Thase ME: Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry 2006; 163: 217-224
6. Strober M, Schmidt-Lackner S, Freeman R, Bower S, Lampert C, DeAntonio M: Recovery and relapse in adolescents with bipolar affective illness: a five-year naturalistic, prospective follow-up. J Am Acad Child Adolesc Psychiatry 1995; 34: 724-731
7. Dittmann S, Biedermann NC, Grunze H, Hummel B, Scharer L, Kleindienst N, Forsthoff A, Matzner N, Walser S, Walden J: The Stanley Foundation Bipolar Network: results of the naturalistic follow-up study (NFS) after 2.5 years of follow-up in the German centres. Neuropsychobiology 2002; 46(suppl 1): 2-9
8. Gonzalez-Pinto A, Barbeito S, Alonso M, Alberich S, Haidar MK, Vieta E, Tabares-Seisdedos R, Zorrilla I, Gonzalez-Pinto MA, Lopez P: Poor long-Term prognosis in mixed bipolar patients: 10-year outcomes in the Vitoria prospective naturalistic study in Spain. J Clin Psychiatry 2011; 72: 671-676
9. Kulkarni J, Filia S, Berk L, Filia K, Dodd S, de CA, Brnabic AJ, Lowry AJ, Kelin K, Montgomery W, Fitzgerald PB, Berk M: Treatment and outcomes of an Australian cohort of outpatients with bipolar I or schizoaffective disorder over twenty-four months: implications for clinical practice. BMC Psychiatry 2012; 12: 228
10. Vieta E, Gunther O, Locklear J, Ekman M, Miltenburger C, Chatterton ML, Astrom M, Paulsson B: Effectiveness of psychotropic medications in the maintenance phase of bipolar disorder: a meta-Analysis of randomized controlled trials. Int J Neuropsychopharmacol 2011; 14: 1029-1049
11. Simhandl C, Konig B, Amann BL: A prospective 4-year naturalistic follow-up of treatment and outcome of 300 bipolar I and II patients. J Clin Psychiatry 2014; 75: 254-262
12. Moller HJ: Effectiveness studies: advantages and disadvantages. Dialogues Clin Neurosci 2011; 13: 199-207
13. Tohen M, Frank E, Bowden CL, Colom F, Ghaemi SN, Yatham LN, Malhi GS, Calabrese JR, Nolen WA, Vieta E, Kapczinski F, Goodwin GM, Suppes T, Sachs GS, Chengappa KR, Grunze H, Mitchell PB, Kanba S, Berk M: The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders. Bipolar Disord 2009; 11: 453-473
14. Popovic D, Reinares M, Goikolea JM, Bonnin CM, Gonzalez-Pinto A, Vieta E: Polarity index of pharmacological agents used for maintenance treatment of bipolar disorder. Eur Neuropsychopharmacol 2012; 22: 339-346
15. Paykel ES, Abbott R, Morriss R, Hayhurst H, Scott J: Sub-syndromal and syndromal symptoms in the longitudinal course of bipolar disorder. Br J Psychiatry 2006; 189: 118-123
16. Fava GA: Subclinical symptoms in mood disorders: pathophysiological and therapeutic implications. Psychol Med 1999; 29: 47-61
17. Post RM, Leverich GS, Kupka RW, Keck PE Jr, McElroy SL, Altshuler LL, Frye MA, Luckenbaugh DA, Rowe M, Grunze H, Suppes T, Nolen WA: Early-onset bipolar disorder and treatment delay are risk factors for poor outcome in adulthood. J Clin Psychiatry 2010; 71: 864-872
18. Radua J, Mataix-Cols D: Voxel-wise metaanalysis of grey matter changes in obsessivecompulsive disorder. Br J Psychiatry 2009; 195: 393-402
19. Fava GA, Guidi J, Rafanelli C, Sonino N: The clinical inadequacy of evidence-based medicine and the need for a conceptual framework based on clinical judgment. Psychother Psychosom 2015; 84: 1-3
20. Therneau T, Lumley T: Survival. https: //cran.r-project.org/web/packages/survival/index. html
21. Schwarzer G: Meta. https: //cran.r-project. org/web/packages/meta/index.html
22. Moher D, Liberati A, Tetzlaff J, Altman DG: Preferred reporting items for systematic reviews and meta-Analyses: the PRISMA statement. BMJ 2009; 339: b2535
23. Tohen M, Waternaux CM, Tsuang MT: Outcome in mania: a 4-year prospective followup of 75 patients utilizing survival analysis. Arch Gen Psychiatry 1990; 47: 1106-1111
24. De Dios C, Ezquiaga E, Agud JL, Vieta E, Soler B, Garcia-Lopez A: Subthreshold symptoms and time to relapse/recurrence in a community cohort of bipolar disorder outpatients. J Affect Disord 2012; 143: 160-165
25. Montoya A, Tohen M, Vieta E, Casillas M, Chacon F, Polavieja P, Gilaberte I: Functioning and symptomatic outcomes in patients with bipolar I disorder in syndromal remission: a 1-year, prospective, observational cohort study. J Affect Disord 2010; 127: 50-57
26. Strakowski SM, Tsai SY, DelBello MP, Chen CC, Fleck DE, Adler CM, Arndt S, Amicone J: Outcome following a first manic episode: cross-national US and Taiwan comparison. Bipolar Disord 2007; 9: 820-827
27. Goetz I, Tohen M, Reed C, Lorenzo M, Vieta E: Functional impairment in patients with mania: baseline results of the EMBLEM study. Bipolar Disord 2007; 9: 45-52
28. Tundo A, Calabrese JR, Marchetti F, Dell'Osso L, Proietti L, De Filippis R: Continuous circular cycling in bipolar disorder as a predictor of poor outcome. J Affect Disord 2013; 150: 823-828
29. Geller B, Tillman R, Bolhofner K, Zimerman B: Child bipolar I disorder: prospective continuity with adult bipolar I disorder; characteristics of second and third episodes; predictors of 8-year outcome. Arch Gen Psychiatry 2008; 65: 1125-1133
30. Kraemer S, Minarzyk A, Eppendorfer S, Henneges C, Hundemer HP, Wilhelm S, Grunze H: Comparably high retention and low relapse rates in different subpopulations of bipolar patients in a German non-interventional study. BMC Psychiatry 2013; 13: 193
31. Frecska E, Kovacs AI, Balla P, Falussy L, Ferencz A, Varga Z: The message of the survival curves. 1. Composite analysis of long-Term treatment studies in bipolar disorder. Neuropsychopharmacol Hung 2012; 14: 155-164
32. Gitlin MJ, Swendsen J, Heller TL, Hammen C: Relapse and impairment in bipolar disorder. Am J Psychiatry 1995; 152: 1635-1640
33. Geddes JR, Carney SM, Davies C, Furukawa TA, Kupfer DJ, Frank E, Goodwin GM: Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet 2003; 361: 653-661
34. Angst J, Gamma A, Sellaro R, Lavori PW, Zhang H: Recurrence of bipolar disorders and major depression: a life-long perspective. Eur Arch Psychiatry Clin Neurosci 2003; 253: 236-240
35. Mantere O, Suominen K, Valtonen HM, Arvilommi P, Leppamaki S, Melartin T, Isometsa E: Differences in outcome of DSM-IV bipolar I and II disorders. Bipolar Disord 2008; 10: 413-425
36. Born C, Seitz NN, Grunze H, Vieta E, Dittmann S, Seemuller F, Amann B: Preliminary results of a fine-grain analysis of mood swings and treatment modalities of bipolar I and II patients using the daily prospective life-chartmethodology. Acta Psychiatr Scand 2009; 120: 474-480
37. Judd LL, Akiskal HS, Schettler PJ, Coryell W, Endicott J, Maser JD, Solomon DA, Leon AC, Keller MB: A prospective investigation of the natural history of the long-Term weekly symptomatic status of bipolar II disorder. Arch Gen Psychiatry 2003; 60: 261-269
38. Kupka RW, Altshuler LL, Nolen WA, Suppes T, Luckenbaugh DA, Leverich GS, Frye MA, Keck PE Jr, McElroy SL, Grunze H, Post RM: Three times more days depressed than manic or hypomanic in both bipolar I and bipolar II disorder. Bipolar Disord 2007; 9: 531-535
39. Judd LL, Akiskal HS, Schettler PJ, Endicott J, Leon AC, Solomon DA, Coryell W, Maser JD, Keller MB: Psychosocial disability in the course of bipolar I and II disorders: a prospective, comparative, longitudinal study. Arch Gen Psychiatry 2005; 62: 1322-1330
40. Carvalho AF, Sharma MS, Brunoni AR, Vieta E, Fava GA: The safety, tolerability and risks associated with the use of newer generation antidepressant drugs: a critical review of the literature. Psychother Psychosom 2016; 85: 270-288
41. Offidani E, Fava GA, Tomba E, Baldessarini RJ: Excessive mood elevation and behavioral activation with antidepressant treatment of juvenile depressive and anxiety disorders: a systematic review. Psychother Psychosom 2013; 82: 132-141
42. Sani G, Napoletano F, Vohringer PA, Sullivan M, Simonetti A, Koukopoulos A, Danese E, Girardi P, Ghaemi N: Mixed depression: clinical features and predictors of its onset associated with antidepressant use. Psychother Psychosom 2014; 83: 213-221
43. Altshuler LL, Post RM, Black DO, Keck PE Jr, Nolen WA, Frye MA, Suppes T, Grunze H, Kupka RW, Leverich GS, McElroy SL, Walden J, Mintz J: Subsyndromal depressive symptoms are associated with functional impairment in patients with bipolar disorder: results of a large, multisite study. J Clin Psychiatry 2006; 67: 1551-1560
44. Fava GA, Bech P: The concept of euthymia. Psychother Psychosom 2016; 85: 1-5
45. Frye MA, Yatham LN, Calabrese JR, Bowden CL, Ketter TA, Suppes T, Adams BE, Thompson TR: Incidence and time course of subsyndromal symptoms in patients with bipolar I disorder: an evaluation of 2 placebo-controlled maintenance trials. J Clin Psychiatry 2006; 67: 1721-1728
46. Isasi AG, Echeburua E, Liminana JM, Gonzalez-Pinto A: How effective is a psychological intervention program for patients with refractory bipolar disorder? A randomized controlled trial. J Affect Disord 2010; 126: 80-87
47. Novo P, Landin-Romero R, Radua J, Vicens V, Fernandez I, Garcia F, Pomarol-Clotet E, McKenna PJ, Shapiro F, Amann BL: Eye movement desensitization and reprocessing therapy in subsyndromal bipolar patients with a history of traumatic events: a randomized, controlled pilot-study. Psychiatry Res 2014; 219: 122-128
48. Calabrese JR, Vieta E, El Mallakh R, Findling RL, Youngstrom EA, Elhaj O, Gajwani P, Pies R: Mood state at study entry as predictor of the polarity of relapse in bipolar disorder. Biol Psychiatry 2004; 56: 957-963
49. Grimmer Y, Hohmann S, Poustka L: Is bipolar always bipolar? Understanding the controversy on bipolar disorder in children. F1000Prime Rep 2014; 6: 111
50. Solomon DA, Leon AC, Coryell WH, Endicott J, Li C, Fiedorowicz JG, Boyken L, Keller MB: Longitudinal course of bipolar I disorder: duration of mood episodes. Arch Gen Psychiatry 2010; 67: 339-347